Top Markets
#1 PulseChain PulseChain +43.68%
#2 Not in Employment, Education, or Training Not in Employment, Education, or Training +6.51%
#3 Bitcoin SV Bitcoin SV +4.90%
#4 Fake World Assets Fake World Assets +4.35%
#5 eCash eCash +3.82%
#6 Shuffle Shuffle +3.57%
#7 Magma Finance Magma Finance +3.00%
#8 HOME HOME +2.48%
#9 AI XOVIA AI XOVIA +2.28%
#10 Morpho Morpho +2.27%
Coin of the day
PulseChain PulseChain
Settings
Language
ENGLISH
Currency
USD
Theme
MegaPro Biomedical Co., Ltd MegaPro Biomedical Co., Ltd

MegaPro Biomedical Co., Ltd

6827
Rank in Stocks #28596
MegaPro Biomedical Co., Ltd. operates as a biotechnology enterprise primarily... MegaPro Biomedical Co., Ltd. operates as a biotechnology enterprise primarily focused on pioneering nanodrugs. Its innovative development pipeline includes MPB-1523, an IOP injection currently in Phase II clinical evaluation for addressing hepatocellular carcinoma. Simultaneously, MPB-1514, an iron injection, is also undergoing Phase II clinical trials, targeting iron deficiency anemia. Furthermore, the firm is advancing MPB-1734, an anti-cancer pharmaceutical, which is in preclinical assessment for the treatment of malignant tumors. Established in 2014, this company is headquartered in Zhubei, Taiwan.
Share Price
$0.32276013
Last synced: 2026-08-17
Market Cap
$25.60M
Change (1 day)
0.00%
Change (1 year)
-37.52%
Country
TW
Trade MegaPro Biomedical Co., Ltd (6827)

Category

Healthcare
Earnings for MegaPro Biomedical Co., Ltd (6827)
Earnings in 2026 TTM: 0
According to MegaPro Biomedical Co., Ltd latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for MegaPro Biomedical Co., Ltd from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH